Amy Calistri
Stock of the Month
Stephen Leeb
Income Performance Report
Roger Conrad
The Utility Forecaster
Paul McWilliams
Next Inning

Cameco gets boost from China


Bookmark and Share
by Gordon Pape, editor Internet Wealth Builder

It's been a rough time for Cameco Corp. (CCJ), the world's number one uranium producer. The stock fell as low as C$17.25 in late November, a level it hadn't seen since the crash of 2008-09.

However, the company recently got a boost when Prime Minister Stephen Harper announced a deal to remove restrictions on the sale of uranium to China during a visit to Beijing.

Canadian producers will now be allowed to sell uranium yellowcake for use in Chinese nuclear power plants, an area that had previously been off-limits.
Advertisement
Banner

The Chinese market is one of the fastest growing in the world and Canada's exclusion has frustrated Cameco and other Canadian producers.

The Saskatoon-based company said after the news was announced that it can begin to deliver 52 million pounds of yellowcake worth up to $3 billion to China this spring.

Cameco aso announced fourth-quarter results; revenue increased by 45% over the same quarter last year to $977 million. Net earnings were up 29% to $265 million ($0.67 a share).

However, for the full 2011 fiscal year, earnings were off 13% to $450 million ($1.14 per share) compared to $516 million ($1.31 per share) in 2010.

Commenting on the state of the nuclear industry, the company said that the near to medium outlook is uncertain due to the after-effects of last year's disaster at Japan's Fukushima-Daiichi nuclear power station.

Action now: The road back will take time but the deal with China is an important development for Cameco. The stock is a Buy for aggressive investors.

Learn more about this financial newsletter at Gordon Pape's Internet Wealth Builder.


Related articles:

Banner
News Flash

Linkedin: Professional profits
by Leo Fasciocco, editor Ticker Tape Digest

Online professional network operator Linkedin (LNKD) recently moved above its technical breakout point of $108.53. We now target a move to $138.


Read more...

 

Tap in to water stocks
by Doug Fabian, editor Making Money Alert

As we prepare for the summer heat, water presents a significant investment opportunity -- especially as states such as California and Texas face droughts. The PowerShares Water Resource ETF (PHO) presents one way to invest in water's untapped potential.


Read more...


   

Pax World: High yield exception
by Amy Calistri, editor The Daily Paycheck

I generally prefer closed-end or exchange-traded funds because the fees tend to be lower. But I made a special case for Pax World High Yield Bond (PAXHX); this high-yield bond fund is my only open-ended mutual fund holding.


Read more...

 

Amgen: Biotech DRIP
by Chuck Carlson, editor DRIP Investor

Amgen (AMGN) is one of the oldest and largest players in the biotechnology area. It pioneered the development of products based on advances in recombinant DNA and molecular biology, launching the biotechnology industry’s first blockbuster medicines.


Read more...

 

Fidelity fund expert looks to Japan
by Jim Lowell, editor Fidelity Investor

In my May Marketwatch investment strategy column I noted, “Set against the backdrop of having already been thrown out with the Eurozone’s bathwater, I like Japan’s marketplace overall and, more specifically, their small cap marketplace which caters to domestic counter traffic.”


Read more...

 

MOO: Market Vectors Agribusiness
by Doug Fabian, editor Making Money Alert

Everyone needs food to survive, so wouldn't it be great to make money from it? We can. The global agriculture business provides a fairly stable investment with growth potential. In particular, I am looking at Market Vectors Agribusiness ETF (MOO).


Read more...

 

Celgene: Selloff creates opportunity
by J. Royden Ward, editor Cabot Benjamin Graham Value Letter

Celgene (CELG) develops and assists in the marketing of drugs to treat cancer and infl ammatory diseases. It acquired several companies recently, which will expand its product line and add promising products in various stages of development.


Read more...

 

Senior housing reits for income
by Brian Hicks, editor Wealth Advisory

Omega Healthcare Investors (OHI) and Medical Properties Trust (MPW) caters to the senior housing/assisted living facilities. Given the growing senior population, it makes sense to be somewhat over-exposed to companies that target this market.


Read more...

 

Buffett: Still banking on banks
by Ron Rowland, editor All Star Investor

Wise investors zero in on conflicting data points. Warren Buffett, the wisest investor of all, provided plenty to consider at the Berkshire Hathaway annual meeting. 


Read more...

 

Questcor: 'Exponential demand'
by Dennis Slothower, editor Stealth Stocks

Questcor Pharmaceuticals (QCOR), our latest featured stock of the month, is a biopharmaceutical company whose primary product helps patients with serious, difficult-to-treat medical conditions.


Read more...

 



Banner



Close
Select Offer: Schwab Options Market Commentary